A shadow market for unapproved weight-loss drugs is propelled by social media fitness personalities and sellers on communication apps, according to recent findings.
Experimental Drug Acquiring Traction Via Social Media
The experimental drug, which remains in research studies, is being advertised by social media influencers for its supposed fat-burning properties. Followers are urged to message these accounts directly for supplier links, while also obtaining discount codes.
Thriving Commerce on Social Networks
Separately, a flourishing market exists on Telegram, where communities with numerous of members share “before and after” images, administration instructions and claims of next-day British shipping. Vendors market the drug there before redirecting customers to other platforms for transactions.
Learning About Retatrutide
Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could help patients lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.
Healthcare Professionals Voice Worries
Nevertheless, physicians and pharmacists have cautions that the distribution of what remains an unlicensed drug in the UK is a cause for concern and could lead to users injecting products of unknown origin.
Several experts stated the demand for the experimental drug could be connected to the rising price of approved weight loss products such as Mounjaro.
Legal Status and Enforcement
Selling the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unapproved medication that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Some content creators attempt to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still breach medicines, advertising, and customer laws, risking fines, prosecution or prison.
Platform Response and Material Removal
According to the social media company, the platform has removed violative material and banned related keywords and search suggestions. The company said it was dedicated to maintaining the service safe and investing in enhancing enforcement strategies.
Online Trading Activities
Investigations also found communities with up to 9,000 members marketing retatrutide using Telegram's built-in search feature, which functions like a public directory. Typing “retatrutide” immediately brings up channels with thousands of members, filled with images of weight loss, glowing testimonials and step-by-step guides for mixing or administering at home.
Within moments of entering one group, a seller posted WhatsApp details, where most transactions take place. The seller sent an guidebook and guaranteed delivery within 48 hours. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about weight, health issues or past usage.
Product Details and Costs
Within these communities, posts show dark colored parcels with Royal Mail stickers, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at home with sterile water, or ready-to-use pens typically sold at £160 for 20mg. When questioned how long a injector should be used, vendors give conflicting responses varying between a few weeks to “depends on your body”.
Service Oversight and Security Actions
A spokesperson for Telegram stated it regularly monitored harmful content on its service including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are administering materials they cannot confirm. Although the research behind retatrutide is valid, these online products may not contain what they claim,” said a pharmacy expert, the head of pharmacy at a pharmacy service.
A medical professional of Asda Online Doctor linked the increase in demand to current cost increases for approved slimming medications such as Mounjaro. “With prices increasing, patients are turning to social media. But fake injections are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she said.
Her team has already encountered patients injured by personal administration from unconfirmed sources. “We recognize the frustration, but buying from Telegram or communication platforms is taking chances with your well-being,” said Wyllie. “These materials could be impure or incorrectly dosed.”
Producer Position
A representative from Eli Lilly stated the substance was in phase 3 research studies and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for human use,” they said, noting that any item “misleadingly claiming itself as a company investigational product not yet approved … may expose patients to possibly significant health risks”.
